|
BE637271A
(enExample)
|
1963-04-04 |
1900-01-01 |
|
|
|
NL128365C
(enExample)
|
1963-11-05 |
|
|
|
|
US3449427A
(en)
|
1965-06-03 |
1969-06-10 |
Smithkline Corp |
Aminocyclopropane derivatives of 5h-dibenzo(a,d)cycloheptenes
|
|
US3697506A
(en)
|
1970-08-07 |
1972-10-10 |
Pfizer |
Crystalline alkali metal salts of {60 -carboxybenzylpenicillin and process therefor
|
|
US3686335A
(en)
|
1970-12-21 |
1972-08-22 |
Smith Kline French Lab |
5-vinyl-5h-di benzo(a,d)cycloheptenes
|
|
US4432987A
(en)
|
1982-04-23 |
1984-02-21 |
Pfizer Inc. |
Crystalline benzenesulfonate salts of sultamicillin
|
|
US4547505A
(en)
|
1983-03-25 |
1985-10-15 |
Degussa Aktiengesellschaft |
N-Phenyl-N-'-cycloalkylalkanoylpiperazine useful as analgetics and process for its production
|
|
CS244821B2
(en)
|
1983-06-16 |
1986-08-14 |
Boehringer Ingelheim Ltd |
Production method of new substituted phenylalkyl(piperazinyl or homopiperazinyle)-prpylureas or thioureas
|
|
DE3418167A1
(de)
|
1984-05-16 |
1985-11-21 |
Bayer Ag, 5090 Leverkusen |
Verwendung von amiden zur verbesserung der kulturpflanzen-vertraeglichkeit von herbizid wirksamen heteroaryloxyacetamiden
|
|
DE3600288A1
(de)
|
1986-01-08 |
1987-07-16 |
Bayer Ag |
Verwendung von amiden zur verbesserung der kulturpflanzen-vertraeglichkeit von herbizid wirksamen sulfonylharnstoff-derivaten
|
|
DE3618004A1
(de)
|
1986-05-28 |
1987-12-03 |
Bayer Ag |
Verwendung von amiden zur verbesserung der kulturpflanzen-vertraeglichkeit von herbizid wirksamen sulfonyliso(thio)-harnstoff-derivaten
|
|
JPH05503517A
(ja)
|
1989-12-18 |
1993-06-10 |
バージニア・コモンウェルス・ユニバーシティ |
シグマレセプターリガンド及びその用途
|
|
EP0435320B1
(en)
|
1989-12-29 |
1994-10-05 |
Banyu Pharmaceutical Co., Ltd. |
2(2-Cyclopropylpyrrolidin-4-ylthio)-carbapenem derivatives
|
|
DE69227778T2
(de)
|
1991-08-22 |
1999-07-01 |
Monsanto Co., St. Louis, Mo. |
Safener für herbizide pyrazolylsulfonylharnstoffe
|
|
DE4131139A1
(de)
|
1991-09-19 |
1993-03-25 |
Bayer Ag |
Verfahren zur herstellung von 1-fluor-cyclopropan-1-carbonsaeure
|
|
WO1994020505A1
(en)
|
1993-03-12 |
1994-09-15 |
The Upjohn Company |
Crystalline ceftiofur free acid
|
|
CN1088062C
(zh)
|
1994-11-23 |
2002-07-24 |
纽罗根公司 |
某些4－氨基甲基－2－取代的咪唑衍生物2－氨基甲基－4－取代的咪唑衍生物新的一族多巴胺受体亚型特异性配体
|
|
US5604253A
(en)
|
1995-05-22 |
1997-02-18 |
Merck Frosst Canada, Inc. |
N-benzylindol-3-yl propanoic acid derivatives as cyclooxygenase inhibitors
|
|
US5859246A
(en)
|
1997-01-30 |
1999-01-12 |
Neurogen Corporation |
1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands
|
|
JP3476203B2
(ja)
|
1997-02-24 |
2003-12-10 |
ザイモジュネティックス インコーポレイテッド |
カルシトニン擬似体
|
|
US6160134A
(en)
|
1997-12-24 |
2000-12-12 |
Bristol-Myers Squibb Co. |
Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines
|
|
IL137517A0
(en)
|
1998-01-27 |
2001-07-24 |
Aventis Pharm Prod Inc |
Substituted oxoazaheterocyclyl factor xa inhibitors
|
|
US6268367B1
(en)
|
1998-02-23 |
2001-07-31 |
Zymogenetics, Inc. |
Piperazine derivatives for treating bone deficit conditions
|
|
WO2000000492A1
(en)
|
1998-06-26 |
2000-01-06 |
Chugai Seiyaku Kabushiki Kaisha |
FINE POWDER OF L-α-AMINOADIPIC ACID DERIVATIVE, ORAL SOLID PREPARATIONS CONTAINING THE SAME, AND METHOD FOR TREATMENT OF BULK POWDERS
|
|
US6284761B1
(en)
|
1999-01-08 |
2001-09-04 |
Neurogen Corporation |
1-phenyl-4-(1-[2-aryl]cyclopropyl)methylpiperazines: dopamine receptor ligands
|
|
AU771199B2
(en)
*
|
1999-01-08 |
2004-03-18 |
Neurogen Corporation |
1-phenyl-4-(1-(2-aryl)cyclopropyl) methylpiperazines: dopamine receptor ligands
|
|
CA2380860A1
(en)
|
1999-06-16 |
2000-12-21 |
Takeda Chemical Industries, Ltd. |
Benzazepine derivative, production and use thereof
|
|
WO2001022963A1
(en)
|
1999-09-27 |
2001-04-05 |
Merck & Co., Inc. |
Method of preventing osteoporosis
|
|
MXPA02006660A
(es)
|
2000-01-07 |
2002-12-13 |
Transform Pharmaceuticals Inc |
Formacion, identificacion y analisis de diversas formas solidas de alto rendimiento.
|
|
US6521619B2
(en)
|
2000-06-29 |
2003-02-18 |
Icos Corporation |
Aryl phenylcyclopropyl sulfide derivatives and their use as cell adhesion inhibiting anti-inflammatory and immune suppressive agents
|
|
WO2002002522A1
(en)
|
2000-06-29 |
2002-01-10 |
Abbott Laboratories |
Aryl phenycyclopropyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
|
|
KR20030024799A
(ko)
|
2000-07-20 |
2003-03-26 |
뉴로젠 코포레이션 |
캡사이신 수용체 리간드
|
|
KR20030062447A
(ko)
|
2000-12-25 |
2003-07-25 |
아지노모토 가부시키가이샤 |
광학 활성 할로하이드린 화합물의 제조방법
|
|
UA75392C2
(en)
|
2001-02-23 |
2006-04-17 |
Merck & Co Inc |
N-substituted non-aryl heterocyclic antagonists nmda/nr2b
|
|
ATE449090T1
(de)
|
2001-07-02 |
2009-12-15 |
High Point Pharmaceuticals Llc |
Substituierte piperazin- und diazepanderivate zur verwendung als histamin h3 rezeptormodulatoren
|
|
WO2003014110A1
(en)
|
2001-08-08 |
2003-02-20 |
Takeda Chemical Industries, Ltd. |
Benzazepine derivative, process for producing the same, and use
|
|
JP2005508321A
(ja)
|
2001-09-26 |
2005-03-31 |
メルク エンド カムパニー インコーポレーテッド |
結晶形態のエルタペネムナトリウム
|
|
US20050143372A1
(en)
|
2001-10-30 |
2005-06-30 |
Shomir Ghosh |
Compounds, pharmaceutical compositions and methods of use therefor
|
|
US6861432B2
(en)
|
2001-11-23 |
2005-03-01 |
Schering Aktiengesellschaft |
Piperazine derivatives that destabilize androgen receptors
|
|
CN1642947A
(zh)
|
2002-03-22 |
2005-07-20 |
株式会社Lg生命科学 |
( 2 S )－N－5－[氨基(亚氨基)甲基]－2－噻吩基甲基－1－( 2 R ) －2－[(羧甲基) 氨基]－3 ,3－二苯基丙酰－2－吡咯烷甲酰胺·nH2O的新晶形
|
|
WO2003103666A2
(en)
|
2002-06-07 |
2003-12-18 |
Altana Pharma Ag |
Novel 4,5-dihydro-imidazo[4,5,1-ij]quinolin-6-ones
|
|
US20040209858A1
(en)
|
2002-10-22 |
2004-10-21 |
Bennani Youssef L. |
Cycloalkylamides and their therapeutic applications
|
|
US20040077618A1
(en)
|
2002-10-22 |
2004-04-22 |
Bennani Youssef L. |
Cycloalkylamides and their therapeutic applications
|
|
WO2004046110A1
(ja)
|
2002-11-15 |
2004-06-03 |
Yamanouchi Pharmaceutical Co., Ltd. |
メラニン凝集ホルモン受容体拮抗剤
|
|
WO2004055010A2
(en)
|
2002-12-13 |
2004-07-01 |
Smithkline Beecham Corporation |
Cyclopropyl compounds as ccr5 antagonists
|
|
AU2004238447C1
(en)
|
2003-04-23 |
2009-06-11 |
Glaxo Group Limited |
Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases
|
|
ATE522525T1
(de)
|
2003-05-01 |
2011-09-15 |
Bristol Myers Squibb Co |
Arylsubstituierte pyrazolamidverbindungen, die als kinase-inhibitoren von nutzen sind
|
|
AR045595A1
(es)
|
2003-09-04 |
2005-11-02 |
Vertex Pharma |
Composiciones utiles como inhibidores de proteinas quinasas
|
|
WO2005058884A2
(en)
|
2003-12-15 |
2005-06-30 |
Japan Tobacco Inc. |
Cyclopropane compounds and pharmaceutical use thereof
|
|
CA2573198A1
(en)
|
2004-07-06 |
2006-02-09 |
Xenon Pharmaceuticals Inc. |
Nicotinamide derivatives and their use as therapeutic agents
|
|
TW200621760A
(en)
|
2004-09-09 |
2006-07-01 |
Mitsubishi Pharma Corp |
2-morpholino-4-pyrimidone compound
|
|
EP1805164B9
(en)
|
2004-09-29 |
2011-09-07 |
Mitsubishi Tanabe Pharma Corporation |
6-(pyridinyl)-4-pyrimidone derivates as tau protein kinase 1 inhibitors
|
|
PL1802307T3
(pl)
|
2004-10-15 |
2008-07-31 |
Glaxo Group Ltd |
Pochodne pirolidyny jako ligandy receptorów histaminowych
|
|
WO2006071730A1
(en)
|
2004-12-27 |
2006-07-06 |
Astrazeneca Ab |
Pyrazolone compounds as metabotropic glutamate receptor agonists for the treatment of neurological and psychiatric disorders
|
|
EP1844052A1
(en)
|
2005-01-26 |
2007-10-17 |
Pharmacia & Upjohn Company LLC |
Thieno[2,3-d]pyrimidine compounds as inhibitors of adp-mediated platelets aggregation
|
|
EP1848695B1
(en)
|
2005-02-15 |
2011-07-27 |
Glaxo Group Limited |
Compounds which potentiate glutamate receptor and uses thereof in medicine
|
|
SI2607362T1
(sl)
|
2005-02-17 |
2015-03-31 |
Astellas Pharma Inc. |
Piperidinski in piperazinski karboksilati kot FAAH inhibitorji
|
|
CA2602358A1
(en)
|
2005-03-25 |
2006-09-28 |
Pharmacia & Upjohn Company Llc |
4-piperazinnylthieno [2,3-d] pyrimidine compounds as platelet aggregation inhibitors
|
|
CA2603041A1
(en)
|
2005-03-28 |
2006-10-05 |
Pharmacia & Upjohn Company Llc |
4-piperazinylthieno [2, 3-d] pyrimidine compounds as platelet aggregation inhibitors
|
|
US20080194590A1
(en)
|
2005-03-28 |
2008-08-14 |
Pfizer Inc |
4-Piperazinylthieno [2,3-D] Pyrimidine Compounds as Platelet Aggregation Inhibitors
|
|
EP1866317A1
(en)
|
2005-03-28 |
2007-12-19 |
Pharmacia & Upjohn Company LLC |
4-piperazinothieno [2, 3-d] pyrimidine compounds as platelet aggregation inhibitors
|
|
US20070032502A1
(en)
|
2005-07-15 |
2007-02-08 |
Schering Corporation |
Quinazoline derivatives useful in cancer treatment
|
|
TW200740779A
(en)
|
2005-07-22 |
2007-11-01 |
Mitsubishi Pharma Corp |
Intermediate compound for synthesizing pharmaceutical agent and production method thereof
|
|
JP2009506987A
(ja)
|
2005-08-02 |
2009-02-19 |
ニューロゲン コーポレイション |
ジピペラジニルケトンおよび関連する類似体
|
|
SI1948607T1
(sl)
|
2005-09-16 |
2010-07-30 |
Janssen Pharmaceutica Nv |
Ciklopropil amini kot modulatorji histaminskega H3 receptorja
|
|
US8158673B2
(en)
|
2005-10-27 |
2012-04-17 |
Pfizer Inc. |
Histamine-3 receptor antagonists
|
|
JP5185822B2
(ja)
|
2005-10-31 |
2013-04-17 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
シクロプロピル−アミド誘導体の製造方法
|
|
WO2007075895A2
(en)
|
2005-12-21 |
2007-07-05 |
Vertex Pharmaceuticals Incorporated |
Heterocyclic derivatives as modulators of ion channels
|
|
US8119668B2
(en)
|
2005-12-23 |
2012-02-21 |
Nelson Erik B |
Treatment methods employing histamine H3 receptor antagonists, including betahistine
|
|
KR20080085031A
(ko)
|
2006-01-13 |
2008-09-22 |
에프. 호프만-라 로슈 아게 |
사이클로헥실 피페라지닐 메탄온 유도체 및 히스타민 ｈ3수용체 조절제로서의 이의 용도
|
|
CN101384581B
(zh)
|
2006-02-17 |
2013-09-18 |
弗·哈夫曼-拉罗切有限公司 |
作为5ht2/d3调节剂的苯甲酰基-哌啶衍生物
|
|
US20100006010A1
(en)
|
2006-03-01 |
2010-01-14 |
Ihor Hinczak |
Matrix for masonry elements and method of manufacture thereof
|
|
JP2009132621A
(ja)
|
2006-03-13 |
2009-06-18 |
Ajinomoto Co Inc |
シクロプロピルアミド化合物の製造方法
|
|
MX2008012064A
(es)
|
2006-03-23 |
2008-12-17 |
Amgen Inc |
Compuestos de amida 1-fenilsulfonil-diaza-heterociclica y sus usos como moduladores de hidroxiesteroide deshidrogenadas.
|
|
EP2039689A4
(en)
|
2006-05-26 |
2011-12-28 |
Kaneka Corp |
PROCESS FOR PREPARING OPTICALLY ACTIVE 3-AMINO-2-HYDROXYPROPIONIC ACID CYCLOPROPYLAMID DERIVATIVES AND SALTS THEREOF
|
|
US9108948B2
(en)
|
2006-06-23 |
2015-08-18 |
Abbvie Inc. |
Cyclopropyl amine derivatives
|
|
CN101472887A
(zh)
|
2006-06-23 |
2009-07-01 |
艾博特公司 |
作为组胺h3受体调节物的环丙胺衍生物
|
|
EP2044027A2
(en)
|
2006-07-03 |
2009-04-08 |
Vereniging voor christelijk hoger onderwijs, wetenschappelijk onderzoek en patiëntenzorg |
Fused bicyclic compounds interacting with the histamine h4 receptor
|
|
US20090247499A1
(en)
|
2006-08-21 |
2009-10-01 |
Fletcher Joan M |
Sulfonylated piperazines as cannabinoid-1 receptor modulators
|
|
TW200828371A
(en)
|
2006-09-21 |
2008-07-01 |
Matsushita Electric Industrial Co Ltd |
Chip-type filter
|
|
DE102006056526A1
(de)
|
2006-11-30 |
2008-06-05 |
Archimica Gmbh |
Verfahren zur stereoselektiven Synthese von chiralen Epoxiden durch ADH-Reduktion von alpha-Abgangsgruppen-substituierten Ketonen und Cyclisierung
|
|
US7737149B2
(en)
|
2006-12-21 |
2010-06-15 |
Astrazeneca Ab |
N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof
|
|
WO2008147864A2
(en)
*
|
2007-05-22 |
2008-12-04 |
Xenon Pharmaceuticals Inc. |
Methods of using piperazine compounds in treating sodium channel-mediated diseases or conditions
|
|
US8030495B2
(en)
|
2007-05-23 |
2011-10-04 |
Coleman Paul J |
Cyclopropyl pyrrolidine orexin receptor antagonists
|
|
CA2688585A1
(en)
|
2007-06-11 |
2008-12-18 |
F. Hoffmann-La Roche Ag |
Cyclohexyl derivatives
|
|
BRPI0815591B8
(pt)
*
|
2007-08-22 |
2021-05-25 |
Astrazeneca Ab |
composto, composição farmacêutica, e, uso de um composto.
|
|
WO2009043784A1
(en)
|
2007-10-04 |
2009-04-09 |
F. Hoffmann-La Roche Ag |
Cyclopropyl aryl amide derivatives and uses thereof
|
|
AR070107A1
(es)
|
2008-01-15 |
2010-03-17 |
Lilly Co Eli |
R-2-(4-ciclopropansulfonil-fenil)-n-pirazin-2-il-3-(tetrahidropiran-4-il)-propionamida en forma cristalina, composicion farmaceutica que la comprende y su uso para la manufactura de un medicamento util para la prevencion o tratamiento de hiperglicemia
|
|
DE102008049371A1
(de)
|
2008-03-06 |
2009-09-10 |
Mühlbauer Ag |
Einrichtung mit einem RFID-Transponder in einem elektrisch leitfähigen Gegenstand und Herstellungsverfahren hierfür
|
|
CA2721303C
(en)
|
2008-05-08 |
2016-06-28 |
Evotec Ag |
Azetidines and cyclobutanes as histamine h3 receptor antagonists
|
|
CN102137836B
(zh)
|
2008-07-28 |
2015-08-26 |
赛丹思科大学 |
用于治疗代谢疾病的化合物
|
|
CN101462980B
(zh)
|
2009-01-05 |
2013-01-09 |
扬州天辰精细化工有限公司 |
2，6—二氟苯甲酰胺的工业化生产方法
|
|
TW201039825A
(en)
|
2009-02-20 |
2010-11-16 |
Astrazeneca Ab |
Cyclopropyl amide derivatives 983
|
|
AU2011218492B2
(en)
|
2010-02-18 |
2014-11-13 |
Astrazeneca Ab |
New crystalline form of a cyclopropyl benzamide derivative
|
|
WO2011102793A1
(en)
*
|
2010-02-18 |
2011-08-25 |
Astrazeneca Ab |
Solid forms comprising a cyclopropyl amide derivative
|